T. Rowe Price Associates’s Avita Medical RCEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $63K | Buy |
|
|||||
|
2025
Q1 | $95K | Buy |
|
|||||
|
2024
Q4 | $129K | Sell |
|
|||||
|
2024
Q3 | $213K | Sell |
|
|||||
|
2024
Q2 | $159K | Buy |
|
|||||
|
2024
Q1 | $232K | Buy |
|
|||||
|
2023
Q4 | $184K | Buy |
|
|||||
|
2023
Q3 | $193K | Sell |
|
|||||
|
2023
Q2 | $240K | Buy |
|
|||||
|
2023
Q1 | $149K | Sell |
|
|||||
|
2022
Q4 | $100K | Hold |
|
|||||
|
2022
Q3 | $80K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $96K | Buy |
|